OCT 14, 2016 11:14 AM PDT

T Cell Infusion Method Enhances Anti-Cancer Effect

WRITTEN BY: Kara Marker
Enhancing a cancer patient’s own T cells to reduce tumor growth is an up-and-coming cancer therapy that is being used to treat multiple types of tumor growth. A new study from the Medical University of South Carolina, in collaboration with Loyola University, offers a new way to insure that the enhanced T cells survived once they re-enter the body.
Credit: Medical University of South Carolina
Adoptive cell therapy (ACT) began as an immune-boosting cancer treatment as scientists began infusing autologous, melanoma-specific T cells obtained from the patient’s own supply of cells. After obtaining the cells, researchers genetically modify them with therapeutic receptors, activate them, and then stimulate them to proliferating before facilitating a therapeutic re-infusion back into the patient’s bloodstream. 

Unfortunately, rapid proliferation before reinfusion makes T cells increasingly prone to activation induced cell death (AICD), and the best results only occur when the transferred enhanced T cells survive. Fast-forward to this study and the authors’ current goals: how can they prevent AICD to enhance ACT’s effectiveness at targeting cancer, mainly melanoma? After extensive experimentation, they found that culturing the T cells in N-acetyl cysteine (NAC) before re-infusion protects them from AICD, making the immunotherapy increasingly effective and outcomes much more promising in a preclinical model of melanoma.

The collaborative effort led to the researchers seeing significant improvements in T cell persistence and overall outcomes when they added NAC to the in vitro T cell expansion culture. Apparently, NAC prevents increases in a DNA damage marker called yH2AX. Specifically, 40 percent of NAC-cultured T cells were detectable in tumors post-re-infusion as compared to only 1.2 percent of standard-culture T cells. 

"We were really surprised," said senior author of the recent Cancer Research study Christina Voelkel-Johnson, PhD, from the Medical University of South Carolina. "Given the harsh environment T cells encounter within tumors, we did not expect that the number of NAC-cultured T cells would be 33-fold higher than T cells not cultured in NAC." Plus, in mice models, they saw a significant delay of tumor growth in mice receiving T cell re-infusion after being cultured in NAC.

Their studies show that NAC culture reduces the level of reactive oxygen species (ROS), which reduces the amount of damage done to the DNA through an extensive molecular pathway of kinases, tumor proteins, and antibodies. When less DNA damage occurs in T cells, the body’s regulatory cells don’t have to make a choice between repair and cell death, reducing the overall rate of T cells destroyed because of DNA damage.

Next up: how does NAC culturing of T cells affect their phenotype? How does it work? In Voelkel-Johnson’s words: “There may be benefits to culturing T cells in NAC aside from generating AICD resistance that we haven't yet recognized."

More about melanoma:

Melanoma is a cancer that begins in the melanocytes. It’s less common than basal cell and squamous cell skin cancers, but it’s more dangerous because it is more likely to metastasize if not treated early. The American Cancer Society estimates that more than ten thousand people in the United States will die from melanoma in 2016.
 


Sources: Medical University of South Carolina, American Cancer Society
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 17, 2018
Videos
JUL 17, 2018
Encouraging Progress on HIV Vaccine
In the quest to find a vaccine against HIV which causes AIDS, most attempts have failed. The HIV epidemic began about 35 years ago and in that time only fi...
JUL 30, 2018
Immunology
JUL 30, 2018
Traumatic Childhood to Addiction, an Immune System Problem
Childhood adversity alters the immune system which contributes to increased risk of addiction as an adult....
OCT 03, 2018
Immunology
OCT 03, 2018
Let's Cut the Brakes on the Immune System
Two laureates receive Nobel Prize for their work regarding immune checkpoint therapy...
NOV 13, 2018
Immunology
NOV 13, 2018
What Do Heart Disease and Autoimmune Diseases Have in Common?
Researchers at Washington University identify the link between autoimmune diseases and heart disease in mouse model...
NOV 14, 2018
Immunology
NOV 14, 2018
Stress in Youth Can Mean Depression as an Adult
A research team investigates early life stress and its relation to adult depression and anxiety...
NOV 16, 2018
Technology
NOV 16, 2018
Novel 'Cellphone' Technology Detects HIV
Human immunodeficiency virus 1 (HIV), weakens the immune system by attacking healthy cells. Currently, the management of HIV remains a major global health ...
Loading Comments...